Maintain pressure on reforms to protect NHSMHRA warning after drugs manufacturer recalls oral morphine solution
Healthcare professionals have been urged by the government’s drugs and medicines watchdog, the MHRA, to quarantine certain batches of an oral morphine solution.
The Medicines and Healthcare Products Regulatory Agency (MHRA) said drug manufacturer Boehringer/Ingelheim had recalled packs of 10mg/5ml Oramorph Oral Solution.
It had received complaints about deviation in taste and non-serious events and recalled affected batches of the drug, which are listed on the MHRA website.
All affected stock, which is used in hospitals and community pharmacies, should be quarantined and returned for credit, the MHRA said.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.